Land: Australien
Språk: engelska
Källa: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CEPHALEXIN AS CEPHALEXIN MONOHYDRATE
VIRBAC (AUSTRALIA) PTY LTD
cephalexin as monohydrate(75mg/Tb)
ORAL TABLET
CEPHALEXIN AS CEPHALEXIN MONOHYDRATE ANTIBIOTIC Active 75.0 mg/Tb
*1 Tablet; *10 Tabs; *2 Tablets; *3 Tablets; *4 Tablets; *6 Tablets; *Blister; 100 Tabs; 256 Tabs; 259 Tablet; 300 Tabs; 500 Tab
VM - Veterinary Medicine
CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY
ANTIBIOTIC & RELATED
ENTEROBACTER SPP. | ESCHERICHIA COLI (E. COLI) | INFECTIONS OF SOFT CUTANEOUS TISSUE | INFECTIONS OF THE DIGESTIVE TRACT | INFECTIONS OF THE RESPIRATORY TRACT | INFECTIONS OF THE URINARY TRACTS | KLEBSIELLA SPP. | OSTEOMYELITIS | PROTEUS SPP. | SALMONELLA | SHIGELLA SPP. | STAPHYLOCOCCUS AUREUS | ACUTE RESPIRATORY INFECTIONS | BRONCHISEPTICA | BRONCHITIS | ESCHERICHIA COLI | GROUP D STREPTOCOCCUS | INCLUDING B-LACTAMASE PRODUCIN | KLEBSIELLA SPP. | PHARYNGITIS | PNEUMONIA | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | SALMONELLOSIS | STAPHYLOCOCCUS SPP. | TONSILLITIS
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA SPP., OSTEOMYELITIS, PROTEUS SPP., SALMONELLA, SHIGELLA SPP., STAPHYLOCOCCUS AUREUS]; DOG: [ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA SPP., OSTEOMYELITIS, PROTEUS SPP., SALMONELLA, SHIGELLA SPP., STAPHYLOCOCCUS AUREUS]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA SPP., OSTEOMYELITIS, PROTEUS SPP., SALMONELLA, SHIGELLA SPP., STAPHYLOCOCCUS AUREUS]; DOG: [ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA SPP., OSTEOMYELITIS, PROTEUS SPP., SALMONELLA, SHIGELLA SPP., STAPHYLOCOCCUS AUREUS]; For the treatment of bacterial infections susceptible to cephalexin - infections of soft cutaneous tissue, urinary infections, respiratory & digestive infections and prevention & treatment of osteomyelitis.DO NOT use in animals that are hypersensitive to cephalosporins & other penicillins.
Registered
2023-07-01
93 Rookwood Road Yagoona NSW Australia 2199 P 02 9796 3000 F 02 9790 4885 artroom@burwoodpress.com.au www.burwoodpress.com.au SIGNATURE ALTERATIONS TO BE MADE OK TO PROCEED TO COLOUR PROOF OK TO PROCEED TO PRINT Reflex Blue PMS 485 PMS 3395 Dieline Liver flavoured Cephalexin Antibiotic Tablets for Cats and Dogs Rilexine ® Palatable 75 Liver flavoured Cephalexin Antibiotic Tablets for Cats and Dogs Rilexine ® Palatable 75 Liver flavoured Cephalexin Antibiotic Tablets for Cats and Dogs Rilexine ® Palatable 75 DIRECTIONS FOR USE: DIRECTIONS FOR USE: THIS PRODUCT IS CONTRAINDICATED IN ANIMALS THAT ARE HYPERSENSITIVE TO CEPHALOSPORINS AND OTHER PENICILLINS. SIDE EFFECTS: Some dogs may exhibit nausea, vomiting and diarrhoea. DOSAGE AND ADMINISTRATION: CATS AND DOGS: Administer Cephalexin at a dose rate of 15mg/kg bodyweight twice daily (i.e. 1 tablet per 5 kg bodyweight morning and night) or 30 mg/kg bodyweight once a day (2 tablets per 5 kg bodyweight at 24 hour intervals). Long term treatment may be necessary for skin and urinary tract infections. Treatment should be carried out for at least 3 days or at the discretion of a veterinarian. Cephalexin is active against certain strains of Penicillinase producing _Staphylococcus aureus _and also effective for use in urinary infections by susceptible bacterial species. FIRST AID: FIRST AID: IF POISONING OCCURS, CONTACT A DOCTOR OR POISONS INFORMATION CENTRE. PHONE AUSTRALIA 131 126. VIRBAC (AUSTRALIA) PTY. LIMITED 361 Horsley Road, Milperra NSW 2214 Freecall Customer Service Line: 1800 009 847 www.virbac.com.au DISPOSAL: DISPOSAL: Dispose of empty container by wrapping with paper and putting in garbage. STORAGE: STORAGE: Store below 30ºC (Room Temperature). ® Registered Trademark of Virbac. [B]: CODE: 1P6475-1 EXP: APVMA: 54343/75MGX259/0608 PRESCRIPTION ANIMAL REMEDY K E E P O U T O F R E A C H O F C H I L D R E N F O R A N I M A L T R E A T M E N T O N L Y Liver flavoured Cephalexin Antibiotic Tablets for Cats and Dogs Rilexine ® 75 Palatable ACTIVE CONSTITUENT: 75 Läs hela dokumentet
VIRBAC (AUSTRALIA) PTY. LTD. DOCUMENT NO: RILEXENE PALATABLETABLETS REVISION C MATERIAL SAFETY DATA SHEET Product Name: Rilexine Palatable Liver Flavoured Cephalexin Antibiotic Tablets for Cats and Dogs PAGE: 1 OF 5 DATE OF ISSUE 17 SEPTEMBER, 2008 EMERGENCY: VIRBAC: 02 9772 9772 OR 1800 242 100 (BUSINESS HOURS ONLY) POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY COMPANY: VIRBAC (AUSTRALIA) PTY. LTD ABN 77 003 268 871 ADDRESS 361 Horsley Rd, Milperra, NSW 2214, Australia Locked Bag 6000, Milperra Business Centre, NSW 1891, Australia TELEPHONE: (02) 9772 9772 or 1800 242 100 FAX: (02) 9772 9773 EMERGENCY PHONE As above during business hours; answering machine after hours SUBSTANCE: Active ingredient is a cephalosporin type antibiotic. TRADE NAME: Rilexine Palatable Liver Flavoured Cephalexin Antibiotic Tablets for Cats and Dogs PRODUCT USE: Treatment of dogs and cats for bacterial infections susceptible to Cephalosporin. CREATION DATE: JUNE, 2002 REVISION DATE: JANUARY, 2008 SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of ASCC Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good. UN NUMBER: None allocated EMERGENCY OVERVIEW PHYSICAL DESCRIPTION & COLOUR: Tan-brown round tablet, scored on one side. ODOUR: Odour of liver. MAJOR HEALTH HAZARDS: No major health hazards are known. POTENTIAL HEALTH EFFECTS Cephalexin has occasionally been associated with the following side-effects: diarrhoea and rarely antibiotic- associated colitis, nausea Läs hela dokumentet